Development and Manufacturing Services to Get Your Product to Patients
Polpharma Biologics is a biopharmaceutical company with state-of-the-art facilities across Europe. We have multiple international centers of excellence specializing in cell line development, product and process development, clinical manufacturing, commercial scale production and regulatory affairs. We work with our partners to advance their biological pipeline (biosimilars and novel biologics) by providing top-quality contract development and manufacturing services to the industry.
Our Core Capabilities
All the component to take your product from DNA, through IND, through clinical trials and to support your global commercial supply. This includes antibody discovery, cell line development, process development and cGMP manufacturing supported by extensive analytical capabilities.
For microbial processes and manufacturing, we have established separate laboratories with dedicated staff to match our capabilities in mammalian development.
We have exceptional technologies and capabilities that will help deliver fingerprint like similarity, smoothing your route to market. We have a track record in taking biosimilars from cell line development to commercial supply.
We provide drug product development and cGMP manufacturing of sterile biologicals in liquid and lyophilized forms at lab and large-scale. We also operates a state-of-the-art biopharmaceutical cGMP fill & finish plant in Europe.
Portfolio & Partnerships
Polpharma Biologics has its own pipeline of biosimilar and novel therapeutics for out-licensing. We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars or novel therpeutics.